ProCE Banner Activity

CE / CME

Infection Prevention and Antibiotic Stewardship powered by Diagnostics

Video

Watch this on-demand webcast of a live webinar to review the connection between diagnostic and antimicrobial stewardship, and learn about diagnostics in clinical practice and how improved utilization decreases the burden of drug resistant infections.

Physicians: Maximum of 1.25 AMA PRA Category 1 Credits

Pharmacists: 1.25 contact hours (0.125 CEUs)

Released: September 01, 2022

Expiration: August 31, 2023

No longer available for credit.

Share

Faculty

Aura Lucia Leal Castro

Aura Lucia Leal Castro, MD, MSc

Associate Professor
Department of Microbiology
Faculty of Medicine
Universidad Nacional de Colombia

Luis Alfredo Ponce de Leon

Luis Alfredo Ponce de Leon, MD, PhD

Head, Department of Infectious Diseases
Instituto Nacional de Ciencias
Mexico

Provided by

Provided by ProCE, LLC and Clinical Care Options, LLC, in partnership with the Center for Infectious Disease Research and Policy (CIDRAP).

ProCE Banner
ProCE Banner

Partners

Center for Infectious Disease Research and Policy (CIDRAP)

ProCE Banner

Additional Information

Program Medium

This program has been made available online.

This activity is supported by an educational grant from Becton, Dickinson and Company

Provided by ProCE, LLC and Clinical Care Options, LLC, in partnership with the Center for Infectious Disease Research and Policy (CIDRAP).

Target Audience

The target audience for this activity is pharmacists and physicians.

Learning Objectives

At the completion of this activity, the participant will be better able to:

  • Apply diagnostics in clinical practice, and understand how improved utilization decreases the burden of drug resistant infections
  • Explain the importance of the connection between diagnostic and antimicrobial stewardship
  • Describe new guidelines and measurements in Colombia and Latin America

Disclosure

ProCE, LLC and Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE and CCO policy. ProCE and CCO are committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Aura Lucia Leal Castro, MD, MSc: consultant/advisor/speaker: Becton Dickinson, MSD and Pfizer. 

Luis Alfredo Ponce de Leon, MD, PhD has no relevant financial relationships to disclose.

Kristine Moore, MD, MPH has no relevant financial relationships to disclose.

Maya Peters, MPH has no relevant financial relationships to disclose.

Marnie Peterson, PharmD, PhD has no relevant financial relationships to disclose.

CCO and ProCE Staff have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Pharmacists
This activity is jointly provided by ProCE, LLC and CIDRAP (Center for Infectious Disease Research and Policy). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-22-198-L01-P has been assigned to this live knowledge-based activity (initial release date 6-21-2022). This CE activity is approved for 1.25 contact hours (0.125 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by ProCE, LLC and Clinical Care Options, LLC (CCO). Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.